drugset / Trial / NCT00507169
SVT-40776 in Patients Suffering From Overactive Bladder Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The study will examine which dose of SVT-40776 is best in terms of efficacy, safety and tolerability compared to placebo and tolterodine
Timeline
- Start
- 2006-09
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SVT-40776 | Unknown | — | — |